Year: All Releases20192018201720162015201420132012 March 8, 2019 Mersana Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates PDF Version March 6, 2019 Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference PDF Version March 5, 2019 Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares PDF Version March 1, 2019 Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2018 Financial Results and Business Updates PDF Version March 1, 2019 Mersana Therapeutics Announces Pricing of Public Offering of Common Stock PDF Version February 28, 2019 Mersana Therapeutics Announces Proposed Public Offering of Common Stock PDF Version February 20, 2019 Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference PDF Version January 4, 2019 Mersana Therapeutics Announces Strategic Priorities and Goals for 2019 and Beyond PDF Version January 2, 2019 Mersana Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference PDF Version November 27, 2018 Mersana Therapeutics Appoints Dirk Huebner, M.D., as Chief Medical Officer PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
